Author:
Hupa-Breier Katharina Luise,Jaeckel Elmar
Publisher
Springer Berlin Heidelberg
Reference45 articles.
1. Akinci B, Meral R, Oral EA (2018) Update on therapeutic options in lipodystrophy. Curr Diab Rep 18(12):139
2. Al-Humadi H, Theocharis S, Dontas I, Stolakis V, Zarros A, Kyriakaki A, Al-Saigh R, Liapi C (2012) Hepatic injury due to combined choline-deprivation and thioacetamide administration: an experimental approach to liver diseases. Dig Dis Sci 57(12):3168–3177
3. Bello-Chavolla OY, Kuri-Garcia A, Rios-Rios M, Vargas-Vazquez A, Cortes-Arroyo JE, Tapia-Gonzalez G, Cruz-Bautista I, Aguilar-Salinas CA (2018) Familial combined hyperlipidemia: current knowledge, perspectives, and controversies. Rev Invest Clin 70(5):224–236
4. Bessone F, Dirchwolf M, Rodil MA, Razori MV, Roma MG (2018) Review article: drug-induced liver injury in the context of nonalcoholic fatty liver disease – a physiopathological and clinical integrated view. Aliment Pharmacol Ther 48(9):892–913
5. Bower M, Wunderlich C, Brown R, Scoggins CR, McMasters KM, Martin RC (2013) Obesity rather than neoadjuvant chemotherapy predicts steatohepatitis in patients with colorectal metastasis. Am J Surg 205(6):685–690